Terminated NA INTERVENTIONAL NCT00232128

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

Sponsor: Oncology Specialties, Alabama

Interventions Radiofrequency Ablation of pulmonary neoplasms

Updated 5 times since 2017 Last updated: Jan 11, 2007 Started: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Oncology Specialties, Alabama

More terminations from Oncology Specialties, Alabama

Other Pulmonary Neoplasms trials with similar outcome

NCT00241267 · Mar 2006

Browse all Pulmonary Neoplasms trials

This NA trial investigates Pulmonary Neoplasms and is currently terminated or withdrawn. Oncology Specialties, Alabama leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oncology Specialties, Alabama

Data source: Oncology Specialties, Alabama

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Huntsville, United States